• Plasma, Treatment & therapies, Understanding the diseases
Thomas Kreil is Associate Professor at Institute of Virology in Vienna and Vice President Global Pathogen Safety at Takeda. He provides an overview of health safety processes in the field of plasma-derived medicinal products.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policy